There is some good news in the world of antibiotics.
Novartis quietly snagged supplemental FDA approval for its drug Lamprene over the summer, transitioning a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.